Vir Biotechnology (NASDAQ:VIR – Get Free Report) released its earnings results on Thursday. The company reported ($1.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.21) by ($0.24), Briefing.com reports. The business had revenue of $3.80 million during the quarter, compared to analysts’ expectations of $22.39 million. The company’s quarterly revenue […]
Related Keywords
Canada , United States , America , , Royal Bank , Lazard Asset Management , Financial Services Group Inc , Securities Exchange Commission , Vir Biotechnology Inc , Endurance Cayman Ltd Svf , Needham Company , Vir Biotechnology , Get Free Report , Biotechnology Trading Down , Exchange Commission , Ltd Svf , Financial Advisors , Asset Management , Services Group , Vir Biotechnology Daily , Nasdaq Vir , Ivir , Medical , Earnings ,
comparemela.com © 2020. All Rights Reserved.